Study on the real world and biological evidence of Xiaozheng Sanjie method in the treatment of chronic kidney disease based on traditional Chinese medicine flaccidity theory

Phase 1

• Conditions: Chronic kidney disease

• Registration Number: ITMCTR2100005474
• Lead Sponsor: The First Affiliated Hospital of Chengdu Medical College

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

? Stage 3-4 patients who meet the diagnostic criteria specified in the 2012 KDIGO clinical practice guidelines for chronic kidney disease (CKD) (kidney international supplies. 2013,3:1-150.)
? Age 18-75 years old.
? The patient or his guardian has signed the informed consent before participating in the screening.

Exclusion Criteria

? Acute renal injury caused by various causes.
? Patients with severe primary diseases such as liver and hematopoietic system, serious infection, mental abnormalities and malignant tumors.
? Patients with renal replacement therapy such as hemodialysis, peritoneal dialysis and kidney transplantation.
? Pregnant or lactating women under the age of 18 or over 75.
? Other clinical trials are under way.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Renal function index;